File Download

There are no files associated with this item.

Supplementary

Conference Paper: Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the 3rd generation capsid inhibitor AB-836 in healthy subjects(HS) and subjects with chronic hepatitis B (CHB). Poster Presentation (SAT392)

TitleSafety, tolerability, pharmacokinetics (PK), and antiviral activity of the 3rd generation capsid inhibitor AB-836 in healthy subjects(HS) and subjects with chronic hepatitis B (CHB). Poster Presentation (SAT392)
Authors
Gane, EJJucov, AKolomiichuk, LEley, TBrown, JKing, YMedvedeva, EChernyakhovskyy, MMani, NCole, AGKultgen, SGPamulapati, RThi, EPHarasym, TODugyala, RChaudhari, SSofia, MJChild, MPicchio, GSims, KYuen, RMF
Issue Date2022
Citation
The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, v. 77 n. S1, p. S848-849 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/317582

 

DC FieldValueLanguage
dc.contributor.authorGane, EJ-
dc.contributor.authorJucov, A-
dc.contributor.authorKolomiichuk, L-
dc.contributor.authorEley, T-
dc.contributor.authorBrown, J-
dc.contributor.authorKing, Y-
dc.contributor.authorMedvedeva, E-
dc.contributor.authorChernyakhovskyy, M-
dc.contributor.authorMani, N-
dc.contributor.authorCole, AG-
dc.contributor.authorKultgen, SG-
dc.contributor.authorPamulapati, R-
dc.contributor.authorThi, EP-
dc.contributor.authorHarasym, TO-
dc.contributor.authorDugyala, R-
dc.contributor.authorChaudhari, S-
dc.contributor.authorSofia, MJ-
dc.contributor.authorChild, M-
dc.contributor.authorPicchio, G-
dc.contributor.authorSims, K-
dc.contributor.authorYuen, RMF-
dc.date.accessioned2022-10-07T10:23:10Z-
dc.date.available2022-10-07T10:23:10Z-
dc.date.issued2022-
dc.identifier.citationThe International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, v. 77 n. S1, p. S848-849-
dc.identifier.urihttp://hdl.handle.net/10722/317582-
dc.languageeng-
dc.relation.ispartofThe International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology-
dc.titleSafety, tolerability, pharmacokinetics (PK), and antiviral activity of the 3rd generation capsid inhibitor AB-836 in healthy subjects(HS) and subjects with chronic hepatitis B (CHB). Poster Presentation (SAT392)-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros337756-
dc.identifier.volume77-
dc.identifier.issueS1-
dc.identifier.spageS848-
dc.identifier.epage849-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats